| 3D pathology-guided microdissection. |
42332091 |
Nat Methods |
| Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. |
19777566 |
Mol Carcinog |
| Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. |
15709190 |
Clin Cancer Res |
| Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma. |
22170739 |
Genes Chromosomes Cancer |
| Are Non-invasive Multi-cancer Early Cancer Detection Tests the Future? |
39885052 |
Dig Dis Sci |
| Artificial Intelligence-Triaged 3-Dimensional Pathology to Improve Detection of Esophageal Neoplasia While Reducing Pathologist Workloads. |
37657711 |
Mod Pathol |
| Assessing the Effects of a 3-Dimensional (3D) Pathology Tissue-Processing Workflow on Downstream Molecular Analyses. |
42303047 |
Lab Invest |
| Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. |
19491834 |
Am J Gastroenterol |
| CIMP and colon cancer gets more complicated. |
17938428 |
Gut |
| Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer. |
39308420 |
Int J Cancer |
| Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer. |
40455622 |
JAMA |
| Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival - the FOCUS Consortium. |
36549742 |
BMJ Open |
| Colorectal cancer molecular biology moves into clinical practice. |
20921207 |
Gut |
| Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. |
22688851 |
Am J Gastroenterol |
| Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened. |
37971743 |
|
| CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. |
16708352 |
Genes Chromosomes Cancer |
| Deep-learning triage of three-dimensional pathology datasets for comprehensive and efficient pathologist assessments. |
42587049 |
Nat Biomed Eng |
| Development, characterization, and inter-laboratory validation of methylated human cell free DNA candidate reference materials. |
42152147 |
Clin Epigenetics |
| Discovery and Initial Characterization of Long Intergenic Noncoding RNAs Associated With Esophageal Adenocarcinoma. |
37182784 |
Gastroenterology |
| DNA alkylation and DNA methylation: cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas? |
17339242 |
Gut |
| DNA methylation and gene expression profiling of ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation. |
23024594 |
Sarcoma |
| DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer. |
36171645 |
J Natl Cancer Inst |
| DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. |
23226306 |
PLoS One |
| DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses. |
22139570 |
Epigenetics |
| Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas. |
37294695 |
Cancer Epidemiol Biomarkers Prev |
| Emerging Tests for Noninvasive Colorectal Cancer Screening. |
36539002 |
Clin Gastroenterol Hepatol |
| Epigenetic Alterations in Colitis-Associated Colorectal Cancer. |
41562706 |
Epigenomes |
| Epigenetic biomarkers in esophageal cancer. |
22406828 |
Cancer Lett |
| Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. |
18264139 |
Oncogene |
| Epigenetics and colorectal cancer. |
22009203 |
Nat Rev Gastroenterol Hepatol |
| Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. |
21298349 |
Ann Surg Oncol |
| Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. |
17278092 |
Int J Cancer |
| Gastric (Foveolar)-Type Dysplasia in Barrett's Esophagus: A Clinical, Molecular, and Long-Term Outcome Study. |
40162676 |
Am J Gastroenterol |
| Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. |
23539450 |
Cancer Res |
| Genomic and epigenetic instability in colorectal cancer pathogenesis. |
18773902 |
Gastroenterology |
| Genomic instability and colorectal cancer. |
17024019 |
Curr Opin Gastroenterol |
| Histopathology-based Spatial Profiling of Immune and Molecular Features Predicts Cancer risk in Barrett's Esophagus. |
41292664 |
medRxiv |
| HNF4A Defines Molecular Subtypes and Vulnerability to Transforming Growth Factor β-Pathway Targeted Therapies in Cancers of the Distal Esophagus. |
35934060 |
Gastroenterology |
| Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo. |
23604118 |
Oncogene |
| Insights into the role of DNA methylation in disease through the use of mouse models. |
20427558 |
Dis Model Mech |
| Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. |
17349581 |
Cancer Cell |
| Linking epidemiology to epigenomics--where are we today? |
21149325 |
Cancer Prev Res (Phila) |
| Making the case for DCC and UNC5C as tumor-suppressor genes in the colon. |
18054576 |
Gastroenterology |
| Mapping the core senescence phenotype of primary human colon fibroblasts. |
38385965 |
|
| Molecular Analysis of Persistent and Recurrent Barrett's Esophagus in the Setting of Endoscopic Therapy. |
39007490 |
Clin Transl Gastroenterol |
| Multiplex Digital PCR Assay Targeting DNA Methylation for Early Detection of Cancer. |
41073857 |
Methods Mol Biol |
| Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. |
17985359 |
Genes Chromosomes Cancer |
| Natural History of Colorectal Polyps Undergoing Longitudinal in Vivo CT Colonography Surveillance. |
38289210 |
|
| Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia. |
35705525 |
Clin Cancer Res |
| Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study. |
37975600 |
|
| Pre-cancer: From diagnosis to intervention opportunities. |
37037612 |
Cancer Cell |
| Proliferation and Cdk4 expression in microsatellite unstable colon cancers with TGFBR2 mutations. |
16108056 |
Int J Cancer |
| Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. |
16820927 |
Oncol Rep |
| Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. |
21497289 |
J Mol Diagn |
| RET is a potential tumor suppressor gene in colorectal cancer. |
22751117 |
Oncogene |
| Significance of Crypt Atypia in Barrett's Esophagus: A Clinical, Molecular, and Outcome Study. |
37879518 |
Clin Gastroenterol Hepatol |
| TGF-beta has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines. |
18651288 |
Growth Factors |
| TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. |
19208363 |
Gastroenterology |
| TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta. |
19339207 |
Biochim Biophys Acta |
| The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. |
18425817 |
Int J Cancer |
| The next thing in prognostic molecular markers: microRNA signatures of cancer. |
20551450 |
Gut |
| Top advances of the year: Noninvasive colorectal cancer screening tests. |
41045472 |
Cancer |
| Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. |
17047044 |
Cancer Res |
